Pfizer Inc. today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® ...
An illness that struck more than 160 people who attended a work party in Amherst, N.S. was likely norovirus, says the Nova Scotia Health Authority. The health authority started an investigation after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results